the aid library

Filter

569

Diagnosis and Clinical Management of Chagas Disease: An Increasing Challenge in Non-Endemic Areas

Suárez, C., Nolder, D., García-Mingo, A. Research and reports in tropical medicine (2022) CC

Research and Reports in Tropical Medicine 2022:13 25–40. Chagas disease (CD) is caused by the parasite Trypanosoma cruzi, and it is endemic in Central, South America, Mexico and the South of the United States. It is an important cause of early mortality and morbidity, and it is associated with po ... more

Tuberculosis in the WHO African Region: 2023 progress update - September 2023

World Health Organisation (WHO) (2023) C_WHO

This brief update on tuberculosis (TB) in the African region covers the state of TB in the WHO African region, strategic priorities and targets and the impact of COVID-19 on essential services. This is followed by key figures for the region, the role of WHO in country support and, recognizing the im ... more

Setting Up a Cancer Centre: A WHO–IAEA Framework

World Health Organization WHO; International Atomic Energy Agency IAEA (1989) C1

Cancer centres are a major resource in ensuring a comprehensive approach to cancer treatment and its planning. As part of a new roadmap developed by WHO and IAEA to help countries design national cancer control programmes, this publication proposes a framework to develop a cancer centre and/or to st ... more

National Strategic Plan for Tuberculosis 2016-2020

The Republic of the Union of Myanmar, Ministry of Health and Sports (2016) C1

National Tuberculosis Programme
The National Strategic Plan (NSP) for Tuberculosis (TB) 2016-2020 builds on the past experiences for the National Tuberculosis Programme and its partners. This NSP provides a roadmap for delivering quality TB prevention and care service to the entire population, ... more

Guidelines for Health Staff Caring for Gender-based Violence Survivors: Including Protocol for Clinical Management of Rape [EN]

UN High Commissioner for Refugees, Protection Cluster, Health Cluster (2016) C1

Gender-based violence, including rape is a problem throughout the world, occurring in every society, country and region. Refugees and internally displaced people are particularly at risk of this violation during every phase of an emergency situation. The systematic use of sexual violence as a method ... more

Anti-tuberculosis drug resistance among tuberculosis patients in Ukraine and risk factors for MDR-TB

World Health Organization Europe (2016) C_WHO

Results of the first national survey, 2013–2014

India: Nutrition Guidelines for HIV-Exposed and Infected Children (0-14 Years of Age)

Department of Aids Control, NACO, Ministry of Health and Family Welfare, Government of India (2013) C1

Cities ending the AIDS epidemic

Fast-Track Cities; UNAIDS (Joint United Nations Programme on HIVAIDS); Mairie de Paris; et al. (2016) C2

UNAIDS / 2016

Interim Guidance on Public Health and Social Measures for COVID-19 Preparedness and Response Operations in Low Capacity and Humanitarian Settings

Inter-Agency Standing Committee IASC (2020) C1

This Interim Guidance outlines how key public health and social measures needed to reduce the risk of COVID-19 spread and the impact of the disease can be adapted for use in low capacity and humanitarian settings. The recommendations outlined here need to be adjusted to the scale of transmission, co ... more

Protect the Progress: Rise, Refocus, Recover - 2020 Progress Report on the Every Woman Every Child Global Strategy for Women’s, Children’s and Adolescents’ Health (2016–2030)

UNICEF, World Health Organisation (2020) C_WHO

Conflict, climate crisis and COVID-19 pose great threats to the health of women and children.

Xpert Ultra versus Xpert MTB/RIF for pulmonary tuberculosis and rifampicin resistance in adults with presumptive pulmonary tuberculosis

Zifodaya, J.; et al. Cochrane (2021) C1

Cochrane Database of Systematic Reviews 2021, Issue 2. Art. No.: CD009593. DOI: 10.1002/14651858.CD009593.pub5.

2021 Antibacterial agents in clinical and preclinical development: an overview and analysis

World Health Organization WHO (2022) C_WHO

This report presents an analysis of antibacterial agents in preclinical (third annual review) and clinical (fifth annual review) development. The analysis covers traditional (direct-acting small molecules) and non-traditional antibacterial agents in development worldwide. It evaluates to what extent ... more

ACT-Accelerator Transition Plan (1 Oct 2022 to 31 Mar 2023)

World Health Organization WHO (2022) C_WHO

31 Oct 2022 his plan outlines how the ACT-Accelerator will support countries as the world transitions to long-term COVID-19 control.   Recognizing the evolving nature of the COVID-19 virus and pandemic, the plan outlines changes to ACT-A’s set-up and ways of working, to ensure countries co ... more

WHO Living guideline: Drugs to prevent COVID-19
recommended

World Health Organization WHO (2021) C_WHO

Interim guidance 2 march 2021 Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform ... more

Pediatrics Clinical treatment guidelines

Ministry of Health, Rwanda (2012)

Falling short

International Union Against Tuberculosis and Lung Disease; Treatment Action Group; msh; ec al. (2017)

Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis. Accessed in November 2017.

Standard Operating Procedures - Adherence Guidelines for HIV, TB and NCDs: Training Course for Health Care Workers Participant Guide
recommended

National Department of Health, South Africa (2023) C1

PARTICIPANT GUIDE. This Participant Guide has been designed to assist health facilities and community based non-clinicians to develop skills to provide linkage to care, adherence and retention in care services for chronic conditions